Literature DB >> 20636339

A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages.

Yu Zhou1, Xu Wang, Manqing Liu, Quan Hu, Li Song, Li Ye, Dunjin Zhou, Wenzhe Ho.   

Abstract

Toll-like receptor-3 (TLR-3) recognizes double-stranded RNA and induces multiple intracellular events responsible for innate anti-viral immunity against a number of viral infections. Activation of TLR-3 inhibits human immunodeficiency virus (HIV) replication, but the mechanism(s) underlying the action of TLR-3 activation on HIV are largely unknown. Here we demonstrate that treatment of monocyte-derived macrophages with poly I:C, a synthetic ligand for TLR-3, significantly inhibited HIV infection and replication. Investigation of the mechanisms showed that TLR-3 activation resulted in the induction of type I interferon inducible antiviral factors, including APOBEC3G and tetherin, the newly identified anti-HIV cellular proteins. In addition, poly I:C-treated macrophages expressed increased levels of CC chemokines, the ligands for CCR5. Furthermore, TLR-3 activation in macrophages induced the expression of cellular microRNAs (miRNA-28, -125b, -150, -223 and -382), the newly identified intracellular HIV restriction factors. These findings indicate that TLR-3-mediated induction of multiple anti-HIV factors should be beneficial for the treatment of HIV disease where innate immune responses are compromised by the virus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636339      PMCID: PMC2966756          DOI: 10.1111/j.1365-2567.2010.03270.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  47 in total

Review 1.  Of mice and man: TLR11 (finally) finds profilin.

Authors:  Fanny N Lauw; Daniel R Caffrey; Douglas T Golenbock
Journal:  Trends Immunol       Date:  2005-10       Impact factor: 16.687

Review 2.  Monocyte and macrophage heterogeneity.

Authors:  Siamon Gordon; Philip R Taylor
Journal:  Nat Rev Immunol       Date:  2005-12       Impact factor: 53.106

3.  A new classification for HIV-1.

Authors:  E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

4.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.

Authors:  R Medzhitov; P Preston-Hurlburt; C A Janeway
Journal:  Nature       Date:  1997-07-24       Impact factor: 49.962

5.  Pharmacogenomics of responsiveness to interferon IFN-beta treatment in multiple sclerosis: a genetic screen of 100 type I interferon-inducible genes.

Authors:  Stephen Cunningham; Colin Graham; Michael Hutchinson; Aidan Droogan; Killian O'Rourke; Chris Patterson; Gavin McDonnell; Stanley Hawkins; Koen Vandenbroeck
Journal:  Clin Pharmacol Ther       Date:  2005-12       Impact factor: 6.875

6.  A cellular microRNA mediates antiviral defense in human cells.

Authors:  Charles-Henri Lecellier; Patrice Dunoyer; Khalil Arar; Jacqueline Lehmann-Che; Stephanie Eyquem; Christophe Himber; Ali Saïb; Olivier Voinnet
Journal:  Science       Date:  2005-04-22       Impact factor: 47.728

7.  Targets for human encoded microRNAs in HIV genes.

Authors:  Manoj Hariharan; Vinod Scaria; Beena Pillai; Samir K Brahmachari
Journal:  Biochem Biophys Res Commun       Date:  2005-10-07       Impact factor: 3.575

8.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

9.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

Authors:  R L Willey; D H Smith; L A Lasky; T S Theodore; P L Earl; B Moss; D J Capon; M A Martin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

10.  Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population.

Authors:  Emi Hamano; Minako Hijikata; Satoru Itoyama; Tran Quy; Nguyen Chi Phi; Hoang Thuy Long; Le Dang Ha; Vo Van Ban; Ikumi Matsushita; Hideki Yanai; Fumiko Kirikae; Teruo Kirikae; Tadatoshi Kuratsuji; Takehiko Sasazuki; Naoto Keicho
Journal:  Biochem Biophys Res Commun       Date:  2005-04-22       Impact factor: 3.575

View more
  56 in total

Review 1.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

2.  14-3-3ε and 14-3-3σ inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction.

Authors:  Aisha Qasim Butt; Suaad Ahmed; Ashwini Maratha; Sinéad M Miggin
Journal:  J Biol Chem       Date:  2012-09-14       Impact factor: 5.157

Review 3.  Multiple roles of the coagulation protease cascade during virus infection.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

4.  Exosomes contribute to the transmission of anti-HIV activity from TLR3-activated brain microvascular endothelial cells to macrophages.

Authors:  Li Sun; Xu Wang; Yu Zhou; Run-Hong Zhou; Wen-Zhe Ho; Jie-Liang Li
Journal:  Antiviral Res       Date:  2016-08-03       Impact factor: 5.970

5.  Activation of TLR3/interferon signaling pathway by bluetongue virus results in HIV inhibition in macrophages.

Authors:  Ming Dai; Xu Wang; Jie-Liang Li; Yu Zhou; Ming Sang; Jin-Biao Liu; Jian-Guo Wu; Wen-Zhe Ho
Journal:  FASEB J       Date:  2015-08-21       Impact factor: 5.191

6.  Novel drugs targeting Toll-like receptors for antiviral therapy.

Authors:  Mira C Patel; Kari Ann Shirey; Lioubov M Pletneva; Marina S Boukhvalova; Alfredo Garzino-Demo; Stefanie N Vogel; Jorge Cg Blanco
Journal:  Future Virol       Date:  2014-09       Impact factor: 1.831

7.  TLR3 activation efficiency by high or low molecular mass poly I:C.

Authors:  Yu Zhou; Ming Guo; Xu Wang; Jielang Li; Yizhong Wang; Li Ye; Ming Dai; Li Zhou; Yuri Persidsky; Wenzhe Ho
Journal:  Innate Immun       Date:  2012-10-03       Impact factor: 2.680

8.  Association of Toll-like receptor 3 polymorphisms with chronic hepatitis B and hepatitis B-related acute-on-chronic liver failure.

Authors:  Yihui Rong; Haihan Song; Shaoli You; Bing Zhu; Hong Zang; Yi Zhao; Yongli Li; Zhihong Wan; Hongling Liu; Aimin Zhang; Long Xiao; Shaojie Xin
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

9.  Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes.

Authors:  Yu Zhou; Xu Wang; Li Sun; Li Zhou; Tong-Cui Ma; Li Song; Jian-Guo Wu; Jie-Liang Li; Wen-Zhe Ho
Journal:  FASEB J       Date:  2016-09-07       Impact factor: 5.191

10.  Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.

Authors:  Silvio Antoniak; Kohei Tatsumi; Michael Bode; Swetha Vanja; Julie C Williams; Nigel Mackman
Journal:  J Innate Immun       Date:  2016-11-08       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.